8033 related articles for article (PubMed ID: 2128830)
1. [Quantitative determination of phenoloxidase (EC 1.14.18.1). Spectrophotometry measurement of the activity of mushroom and potato tyrosinase].
Schmidt H
Dermatol Monatsschr; 1990; 176(12):757-61. PubMed ID: 2128830
[TBL] [Abstract][Full Text] [Related]
2. [Quantitative determination of phenoloxidase (EC 1.14.18.1). Absorption behavior of mushroom and potato tyrosinase].
Schmidt H
Dermatol Monatsschr; 1986; 172(5):276-81. PubMed ID: 3087800
[No Abstract] [Full Text] [Related]
3. [Immunohistochemical demonstration of tyrosinase 4 in normal skin and melanocytic tumors].
Kageshita T; Ono T; Arao T; Tomita Y
Nihon Hifuka Gakkai Zasshi; 1987 May; 97(6):685-90. PubMed ID: 3114516
[No Abstract] [Full Text] [Related]
4. Tyrosinase activity in serum from patients with malignant melanoma.
Agrup P; Carstam R; Wittbjer A; Rorsman H; Rosengren E
Acta Derm Venereol; 1989; 69(2):120-4. PubMed ID: 2564228
[TBL] [Abstract][Full Text] [Related]
5. New methodological approach for the rapid and sensitive detection of melanocytes and melanocytic tumours. The DOPA-GA method.
Ichikawa A; Takagi H; Suda K; Yao T
Dermatology; 2009; 219(3):195-201. PubMed ID: 19684380
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of tyrosinase and tyrosinase-related protein-2 mRNA from melanoma cells in blood by real-time polymerase chain reaction.
Johansson M; Arstrand K; Håkansson A; Lindholm C; Kågedal B
Melanoma Res; 2000 Jun; 10(3):213-22. PubMed ID: 10890374
[TBL] [Abstract][Full Text] [Related]
7. Detection of tyrosinase mRNA from the blood of melanoma patients.
Stevens GL; Scheer WD; Levine EA
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
[TBL] [Abstract][Full Text] [Related]
8. [Quantitative determination of phenoloxidase (EC 1.14.18.1). Spectral behavior of incubation solutions in relation to time, enzyme concentration, temperature and layer thickness].
Schmidt H
Dermatol Monatsschr; 1987; 173(10):614-20. PubMed ID: 3123286
[No Abstract] [Full Text] [Related]
9. Results of the determination of serum markers in patients with malignant melanoma.
Lugović L; Situm M; Buljan M; Poduje S; Sebetić K
Coll Antropol; 2007 Jan; 31 Suppl 1():7-11. PubMed ID: 17469741
[TBL] [Abstract][Full Text] [Related]
10. [Heterogeneity of tyrosinases isolated from rat skin, normal human skin, and human melanoma tumors].
Sukhanov VA; D'iakov VL; Lalaev VV; Iakh''iaev AV
Biokhimiia; 1991 Jun; 56(6):1026-35. PubMed ID: 1932336
[TBL] [Abstract][Full Text] [Related]
11. A meta-analysis of reverse transcriptase-polymerase chain reaction for tyrosinase mRNA as a marker for circulating tumor cells in cutaneous melanoma.
Tsao H; Nadiminti U; Sober AJ; Bigby M
Arch Dermatol; 2001 Mar; 137(3):325-30. PubMed ID: 11255333
[TBL] [Abstract][Full Text] [Related]
12. The effect of polyamines on tyrosinase activity.
Galindo JD; Martinez JH; Lopez-Ballester JA; Peñafiel R; Solano F; Lozano JA
Biochem Int; 1987 Dec; 15(6):1151-8. PubMed ID: 3125836
[TBL] [Abstract][Full Text] [Related]
13. Detection of tyrosinase mRNA by an optimised nested RT-PCR in the peripheral blood of patients with advanced malignant melanoma.
Glumac N; Hocevar M; Snoj M; Novakovic S
J Exp Clin Cancer Res; 2001 Dec; 20(4):529-36. PubMed ID: 11876547
[TBL] [Abstract][Full Text] [Related]
14. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
[TBL] [Abstract][Full Text] [Related]
15. Tyrosinase activity in the serum of patients with malignant melanoma.
Sonesson B; Eide S; Ringborg U; Rorsman H; Rosengren E
Melanoma Res; 1995 Apr; 5(2):113-6. PubMed ID: 7620338
[TBL] [Abstract][Full Text] [Related]
16. Prediction of metastases in melanoma patients with positive sentinel node: histological and molecular approach.
Tsutsumida A; Furukawa H; Hata S; Saito A; Yamamoto Y
J Dermatol; 2007 Jan; 34(1):31-6. PubMed ID: 17204098
[TBL] [Abstract][Full Text] [Related]
17. Effect of specific or random c-DNA priming on sensitivity of tyrosinase nested RT-PCR: potential clinical relevance.
Calogero A; Hospers GA; Timmer-Bosscha H; Koops HS; Mulder NH
Anticancer Res; 2000; 20(5B):3545-8. PubMed ID: 11131660
[TBL] [Abstract][Full Text] [Related]
18. Immunological determination of tyrosinase in sera of melanoma-bearing hamsters.
Dernałowicz-Malarczyk E; Kotłowska-Niećko I
Neoplasma; 1980; 27(4):345-53. PubMed ID: 6779209
[TBL] [Abstract][Full Text] [Related]
19. Tyrosinase RT-PCR as a supplement to histology for detecting melanoma and nevus cells in paraffin sections of sentinel lymph nodes.
Starz H; Haas CJ; Schulz GM; Balda BR
Mod Pathol; 2003 Sep; 16(9):920-9. PubMed ID: 13679456
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of 5-S-glutathionyldopa.
Carstam R; Edner C; Hansson C; Lindbladh C; Rorsman H; Rosengren E
Acta Derm Venereol Suppl (Stockh); 1986; 126():1-12. PubMed ID: 3103358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
